This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Susceptibility testing of Anopheles malaria vectors with the neonicotinoid insecticide clothianidin; results from 16 African countries, in preparation for indoor residual spraying with new insecticide formulations

Richard M. Oxborough, Aklilu Seyoum, Yemane Yihdego, Roch Dabire, Virgile Gnanguenon, Francis Wat’senga, Fiacre R. Agossa, Gedeon Yohannes, Sylvester Coleman, Lazarus Musa Samdi, Abdoulaye Diop, Ousmane Faye, Stephen Magesa, Alphaxard Manjurano, Michael Okia, Evelyne Alyko, Hieronymo Masendu, Ibrahima Baber, Arthur Sovi, Jean-Desire Rakotoson, Kenyssony Varela, Bernard Abong’o, Bradford Lucas, Christen Fornadel & Dereje Dengela
Malaria Journal


August 16, 2019

To combat malaria, many countries have used the insecticide Actellic™ 300CS for indoor residual spraying annually for up to four consecutive years. That runs the risk that malaria-carrying mosquitoes will develop resistance to Actellic. The solution: insecticide rotation. But there have been few options until now. Results from tests in 16 African countries show that SumiShield™ 50WG and Fludora Fusion™ WP-SB, which use the ingredient clothianidin, are effective alternatives. The novel way clothianidin works makes cross-resistance with other insecticides unlikely.

Sub-Saharan Africa